AU3857095A - Indolocarbazole derivative preparation - Google Patents

Indolocarbazole derivative preparation

Info

Publication number
AU3857095A
AU3857095A AU38570/95A AU3857095A AU3857095A AU 3857095 A AU3857095 A AU 3857095A AU 38570/95 A AU38570/95 A AU 38570/95A AU 3857095 A AU3857095 A AU 3857095A AU 3857095 A AU3857095 A AU 3857095A
Authority
AU
Australia
Prior art keywords
derivative preparation
indolocarbazole derivative
indolocarbazole
preparation
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38570/95A
Inventor
Eiji Hayakawa
Toshihito Hosokawa
Kunio Ito
Kenji Iwata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU3857095A publication Critical patent/AU3857095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU38570/95A 1994-11-29 1995-11-14 Indolocarbazole derivative preparation Abandoned AU3857095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29519794 1994-11-29
JP6-295197 1994-11-29
PCT/JP1995/002326 WO1996016658A1 (en) 1994-11-29 1995-11-14 Indolocarbazole derivative preparation

Publications (1)

Publication Number Publication Date
AU3857095A true AU3857095A (en) 1996-06-19

Family

ID=17817459

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38570/95A Abandoned AU3857095A (en) 1994-11-29 1995-11-14 Indolocarbazole derivative preparation

Country Status (2)

Country Link
AU (1) AU3857095A (en)
WO (1) WO1996016658A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6706988B2 (en) * 2016-07-20 2020-06-10 日本化薬株式会社 Pharmaceutical composition containing bortezomib

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA828580B (en) * 1981-12-23 1983-10-26 Schering Corp Interferon formulations
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives

Also Published As

Publication number Publication date
WO1996016658A1 (en) 1996-06-06

Similar Documents

Publication Publication Date Title
AU2070795A (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
AUPN012194A0 (en) Alumino-silicate derivatives
AU4877896A (en) Preparation
AU4032397A (en) Imidazoquinazoline derivatives
AU3652895A (en) Naphthyridinone derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU3906295A (en) Pyrrole derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU7738098A (en) Novel tetrahydrobenzindolone derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AU2485595A (en) 1-Pyridyltetrazolinone derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU4136197A (en) Pyrrolocarbazole derivatives
AU2961097A (en) Substituted pyrazolylpyrazole derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU5347496A (en) Ethynylthiazole derivative
AU4622597A (en) Novel pyranoside derivatives
AU4117396A (en) Morpholinoethylamide derivatives
AU689566B2 (en) DC-89 derivatives
AU3685097A (en) N-benzylazolium derivatives
AU3619695A (en) Thioquinolone derivative
AU3860995A (en) Adjusting means
AU3784695A (en) Immunosuppressive cyclolignan derivatives
AU1454895A (en) Diphenyloxazoline derivatives